BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Business

  OPKO Health Reports Third Quarter 2022 Business Highlights and Financial ResultsConference call begins at 4:30 p.m. Eastern time today

  OPKO Health, Inc. reports business highlights and financial results for the three months ended September 30, 2022.

  November 8, 2022

   · 

  10 min read
• Business

  Silk Road Medical Reports Third Quarter 2022 Financial Results

  Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended September 30, 2022.

  November 8, 2022

   · 

  6 min read
• Business

  ClearPoint Neuro Reports Third Quarter 2022 ResultsCompany Reaffirms 2022 Revenue Forecast

  ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced financial results for its third quarter ended September 30, 2022.

  November 8, 2022

   · 

  11 min read
• Business

  AnaptysBio Announces Third Quarter 2022 Financial Results and Provides Pipeline Update

  AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported operating results for the third quarter ended September 30, 2022 and provided pipeline updates.

  November 8, 2022

   · 

  10 min read
• BioForest

  CTI BioPharma to Present at Upcoming November 2022 Conferences

  CTI BioPharma Corp. announced that management will provide a corporate overview at two upcoming investor conferences in New York and London.

  November 8, 2022

   · 

  1 min read
• Business

  Amyris, Inc. Reports Third Quarter 2022 Financial Results

  Amyris, Inc., a leading synthetic biotechnology company accelerating the world’s transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, announced financial results for the third quarter ended September 30, 2022.

  November 8, 2022

   · 

  22 min read
• Business

  Protagonist Reports Third Quarter 2022 Financial Results and Provides Corporate Update

  Protagonist Therapeutics (Nasdaq: PTGX) (“Protagonist” or “the Company”) today reported financial results for the third quarter ended September 30, 2022 and provided a corporate update.

  November 8, 2022

   · 

  12 min read
• Business

  Natera Reports Third Quarter 2022 Financial Results

  Natera, Inc., a global leader in cell-free DNA testing, reported financial results for the third quarter ended September 30, 2022.

  November 8, 2022

   · 

  13 min read
• Business

  Avidity Biosciences Reports Third Quarter 2022 Financial Results and Recent Highlights

  Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced financial results for the third quarter ended September 30, 2022 and highlighted recent corporate progress.

  November 8, 2022

   · 

  10 min read
• Business

  Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2022 and Highlights Recent Corporate Updates

  Heron Therapeutics, Inc. announced financial results for the three and nine months ended September 30, 2022 and highlighted recent corporate updates.

  November 8, 2022

   · 

  13 min read